Vascular disease: Trialling stem cell treatment for vascular disease

Nature Reviews Nephrology 13, 384 (2017). doi:10.1038/nrneph.2017.76 Author: Katharine H. Wrighton In a study of mesenchymal stem cells (MSCs) to treat atherosclerotic renovascular disease, 28 patients received standard medical treatment, 14 of whom also received a single infusion of MSCs. Patients who received MSCs showed no adverse clinical effects. 3 months after treatment, cortical perfusion and
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tags: Research Highlight Source Type: research